DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-543613
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
PHA-543613
×
Maximum Phase:
1
First Approval:
None
UNII:
R36R9KVD6Y
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2
Molecular Weight:
271.32
AlogP:
1.65
PSA:
58.37
HBD:
1.0
HBA:
#RotB:
2.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
ALOFANIB
1
Small molecule
Investigational
Unknown
Unknown
Stomach Neoplasms
Unknown
ALOFANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
LQX7RFK8MZ
Molecule Type:
Small molecule
Molecular Formula:
C19H15N3O6S
Molecular Weight:
413.41
AlogP:
3.46
PSA:
139.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
AZD-6918
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
AZD-6918
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MMV-390048
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MMV-390048
×
Maximum Phase:
1
First Approval:
None
UNII:
0Z5T00JJ10
Molecule Type:
Small molecule
Molecular Formula:
C18H14F3N3O2S
Molecular Weight:
393.39
AlogP:
3.82
PSA:
85.94
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CLN-081
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
CLN-081
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H20N6O
Molecular Weight:
396.45
AlogP:
3.32
PSA:
98.72
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AM-211
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
AM-211
×
Maximum Phase:
1
First Approval:
None
UNII:
SZB129M7SZ
Molecule Type:
Small molecule
Molecular Formula:
C27H27F3N2O4
Molecular Weight:
500.52
AlogP:
5.74
PSA:
78.87
HBD:
2.0
HBA:
#RotB:
9.0
Source:
S-222611
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
S-222611
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
MSC-2364447
1
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
MSC-2364447
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RX-3117
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-3117
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMMITECAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMMITECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
T4H02O147G
Molecule Type:
Small molecule
Molecular Formula:
C34H38N4O6
Molecular Weight:
598.7
AlogP:
4.26
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BARDOXOLONE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BARDOXOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
7HT68L8941
Molecule Type:
Small molecule
Molecular Formula:
C31H41NO4
Molecular Weight:
491.67
AlogP:
6.29
PSA:
95.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ELUBRIXIN TOSYLATE
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
ELUBRIXIN TOSYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
13FVR7WD4P
Molecule Type:
Small molecule
Molecular Formula:
C24H25Cl2FN4O7S2
Molecular Weight:
635.52
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARD-024
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CARD-024
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGULICIANINE ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Optical Imaging; Ultrasonography
Diagnostic agent
PEGULICIANINE ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
F3F6208UMT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-509
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Parkinson Disease
Adenosine A2a receptor antagonist
PBF-509
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C10H8BrN7
Molecular Weight:
306.13
AlogP:
1.19
PSA:
87.44
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TP-3654
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TP-3654
×
Maximum Phase:
1
First Approval:
None
UNII:
EOB0N7BOY4
Molecule Type:
Small molecule
Molecular Formula:
C22H25F3N4O
Molecular Weight:
418.46
AlogP:
5.16
PSA:
62.45
HBD:
2.0
HBA:
#RotB:
4.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DTP-348
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DTP-348
×
Maximum Phase:
1
First Approval:
None
UNII:
2HB46A9CNM
Molecule Type:
Small molecule
Molecular Formula:
C6H11N5O4S
Molecular Weight:
249.25
AlogP:
-1.11
PSA:
133.15
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RG-7602
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
RG-7602
×
Maximum Phase:
1
First Approval:
None
UNII:
4N173XZ7SX
Molecule Type:
Small molecule
Molecular Formula:
C18H19N5O
Molecular Weight:
321.38
AlogP:
2.85
PSA:
77.83
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TEGAVIVINT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Desmoid Tumors; Leukemia
Unknown
TEGAVIVINT
×
Maximum Phase:
1
First Approval:
None
UNII:
18AP231HUP
Molecule Type:
Small molecule
Molecular Formula:
C28H36N4O6S2
Molecular Weight:
588.75
AlogP:
3.79
PSA:
139.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
COMBRETASTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
COMBRETASTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7O62J06F18
Molecule Type:
Small molecule
Molecular Formula:
C18H22O6
Molecular Weight:
334.37
AlogP:
2.7
PSA:
77.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HKI-357
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HKI-357
×
Maximum Phase:
1
First Approval:
None
UNII:
39R3638KZ6
Molecule Type:
Small molecule
Molecular Formula:
C31H29ClFN5O3
Molecular Weight:
574.06
AlogP:
6.68
PSA:
99.51
HBD:
2.0
HBA:
#RotB:
11.0
Source:
1
2
…
63
64
65
66
67
68
69
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA